OMTimes Radio Archives

Could Low Dose Naltrexone (LDN) Be of Benefit?

November 6, 2020

Could Low Dose Naltrexone (LDN) Be of Benefit?

Aired Friday, November 6, 2020 at 4:00 PM PST / 7:00 PM EST

Research with low-dose-Naltrexone (LDN) shows promising results into if and how it reduces symptom severity for some people with conditions such as multiple sclerosis, fibromyalgia, and Crohn’s disease, among other diseases and health disruptions. There is also anecdotal and patient-based evidence that LDN is helpful.

Today’s guest Julia Schopick is the best-selling author of ‘The Power of Honest Medicine,’ which features LDN success stories. In our chat, she shares the history of LDN plus

• How low dose naltrexone works
• How to find medical professionals to assess your specific issues
• What is compounding medication
• How to find out if it might work for you
• Why you should not self-prescribe and more…

About Our Guest:

Julia Schopick is the best-selling author of two books: ‘Honest Medicine: Effective, Time-Tested, Inexpensive Treatments for Life-Threatening Diseases’ (2011) and ‘The Power of Honest Medicine: LDN, an Inexpensive Alternative to the Costly, Toxic Medications Doctors Prescribe for Autoimmune and Other Diseases’ (2018). She wrote her first book because of her advocacy for her late husband, Tim Fisher, a 15-year survivor of a cancerous brain tumor. Julia’s second book, The Power of Honest Medicine, with co-author Don Schwartz, is entirely about Low Dose Naltrexone for autoimmune diseases.

Learn more at

Listen to this insightful and helpful interview first Friday, November 6th, at 7 PM ET and later in podcast. Share this link with family and friends:

The information provided on, Life, and The Autoimmune Hour is for educational purposes only.

Visit the Autoimmune Hour show page

Connect with Sharon Sayler at

#JuliaSchopick #LowDoseNaltrexone #ThePowerOfHonestMedicine #TheAutoimmuneHour #SharonSayler

Play this podcast on Podbean App